Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib

BACKGROUND: First‐generation epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) sometimes causes lung injury, thereby affecting survival. Although pre‐existing interstitial lung abnormal shadow (pre‐ILS) increases the risk of lung injury by EGFR‐TKIs, its impact on osimertinib, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibaki, Ryota, Ozawa, Yuichi, Noguchi, Susumu, Murakami, Yusuke, Takase, Eri, Azuma, Yuichiro, Maebeya, Masaru, Sugimoto, Takeya, Hayata, Atsushi, Hayakawa, Takahiro, Tamaki, Shinya, Nakanishi, Masanori, Teraoka, Shunsuke, Akamatsu, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582680/
https://www.ncbi.nlm.nih.gov/pubmed/35434933
http://dx.doi.org/10.1002/cam4.4750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582680/
https://www.ncbi.nlm.nih.gov/pubmed/35434933
http://dx.doi.org/10.1002/cam4.4750

Ejemplares similares